Search

Steady progress in adjusted EBITDA and strategic priorities

CEO Katarina Gabrielson comments on Oriola’s full-year 2025 results: We delivered steady progress in line with our expectations, and the second half of the year was particularly strong.

Pharmacies

Key numbers CO2 emission reduction Number of pharmaceutical products delivered Employees Locations Services and products supporting your success in the Nordics We offer a broad portfolio of

Sales margin growth and improved adjusted EBITDA

I am pleased with our third-quarter results. They confirm that we are on the right strategic path towards becoming the leading specialist in the wholesale of pharmaceuticals and health products.

First quarter performance in line with expectations

CEO Katarina Gabrielson comments on Oriola’s Q1 2026 results.

Oriola and GSK deepen their partnership in Sweden

Oriola and GlaxoSmithKline (GSK) have a long cooperation in Sweden in logistic services. In the beginning of October 2018, the cooperation was extended to cover also GSK´s vaccine customer service for end-customers.

Karoline Magnusson, Team Lead External Customer Service

What do you do at Oriola? I’m the Team Lead for our External Customer Service function in Sweden. The team provides customer service on behalf of pharmaceutical companies, including partners in the

Oriola Corporation’s Interim Report January-September 2025

Oriola Corporation Stock Exchange Release 30 October 2025 at 8.30 a.m. EET Oriola Corporation’s Interim Report January-September 2025 Sales margin growth and improved adjusted EBITDA July-September

Oriola Corporation’s Interim Report 1 January-31 March 2026

Oriola Corporation Stock Exchange Release 29 April 2026 at 8.30 a.m. EEST Oriola Corporation’s Interim Report 1 January-31 March 2026 First quarter performance in line with expectations January-March

Oriola Corporation’s Financial Statements Release 1 January-31 December 2025

Oriola Corporation Stock Exchange Release 25 February 2026 at 8.30 a.m. EET Oriola Corporation’s Financial Statements Release 1 January-31 December 2025 Steady progress in adjusted EBITDA and

Nordic wholesale expertise for effortless growth

We connect health and wellbeing suppliers and resellers through reliable, sustainable wholesale services. With deep Nordic market knowledge and a broad, high-quality product range, we help suppliers grow their reach and support resellers with reliable access, local expertise, and streamlined operations.